- KR₩133bn
- KR₩146bn
- KR₩62bn
- 14
- 29
- 53
- 19
Annual balance sheet for ICD Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 18,790 | 64,015 | 68,935 | 38,533 | 28,095 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 48,742 | 49,431 | 27,269 | 41,089 | 25,806 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 131,397 | 136,566 | 135,062 | 113,203 | 122,025 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 47,799 | 46,761 | 46,812 | 53,633 | 55,851 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 203,772 | 233,099 | 232,849 | 202,500 | 209,531 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 47,155 | 43,242 | 57,262 | 43,016 | 71,424 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 56,717 | 53,625 | 64,912 | 49,254 | 78,885 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 147,055 | 179,474 | 167,937 | 153,246 | 130,646 |
Total Liabilities & Shareholders' Equity | 203,772 | 233,099 | 232,849 | 202,500 | 209,531 |
Total Common Shares Outstanding |